2026-05733
RegulationListing of Color Additive Exempt From Certification; Spirulina Extract; Delay of Effective Date
Introduced: March 24, 2026
Progress
Summary
The Food and Drug Administration (FDA or we) is announcing a delay of the effective date of our February 6, 2026, final order to amend the color additive regulations to provide for the expanded safe use of spirulina (Arthrospira platensis) extract as a color additive in human foods generally (except for infant formula, certain foods subject to regulation by the U.S. Department of Agriculture (USDA), and foods for which standards of identity have been issued under section 401 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), unless the use of the added color is authorized by such standards) at levels consistent with good manufacturing practice (GMP); to lower the heavy metal specifications for lead, arsenic, and mercury; and to add a specification for cadmium. The delay of the effective date is required by law following the filing of timely objections and a request for a hearing on the final order. This announcement does not reflect a change in our determination that there is a reasonable certainty of no harm from the use of this color additive under the conditions of its intended use. In addition, this announcement does not constitute a determination that all of the issues raised in the submission constitute objections or that a hearing is justified on any objections or requests for a hearing that have been filed.
How This Affects You
Related Bills
HR 8052
To amend title 38, United States Code, to require that a sterile processing technician of the Veterans Health Administration holds an appropriate professional certification, and for other purposes
S 921
Tyler’s Law
HR 8043
To amend title 38, United States Code, to improve the efficiency of the recovery and collection of revenue for the Department of Veterans Affairs Medical Care Collections Fund, and for other purposes
HR 8067
To direct the Secretary of Health and Human Services to carry out a program under which the Secretary will collect data with respect to sickle cell disease in the United States, and for other purposes
S 864
HELP Copays Act
Get personalized insights on this bill
CivicRadar tells you exactly how government actions affect your life based on your location, interests, and profession.